Itamar Medical Ltd and Somnoware Healthcare Systems Inc have entered into a strategic alliance to align technology, marketing efforts, and business operations with the goal of transforming delivery of care, reducing cost, and improving productivity for those involved in the management of sleep apnea.

By tightly integrating Itamar’s home sleep testing device, WatchPAT, with Somnoware’s cloud-based software platform, this alliance will promote the adoption of an Integrated Care Delivery Platform, according to information from the company.

“We have formed this partnership because the current healthcare system, particularly the sleep industry, is at an inflection point,” said Subath Kamalasan, CEO of Somnoware. “Lack of care coordination and interoperability has been a major contributor to the uncontrolled costs of care delivery. Through alliances like these, Somnoware’s integrated platform addresses both these issues by eliminating barriers caused almost exclusively by previously unavailable data and coordination capabilities. Itamar’s WatchPAT is among the most advanced devices for home sleep testing. Through this alliance, we are combining best-of-breed in software and hardware to provide fantastic opportunities for our customers. We will enable them to realize tremendous economic and business benefits. ”

“The economic cost of unmanaged sleep apnea for the US healthcare system is enormous. Only about 20% of sleep apnea patients have been diagnosed,” said Marvin Slosman, president of Itamar Medical Inc. “Our priority is to provide access to easy to use testing devices that can assist undiagnosed patients. Somnoware’s unique approach to managing sleep apnea is getting the attention of influential stakeholders in sleep medicine. By enabling interoperability between WatchPAT and Somnoware, Itamar is leading the way in creating solutions that will enable our customers to reduce cost and transition to an outcomes based model of care.”